Atezolizumab + Bendamustine & Obinutuzumab - No major safety signals in follicular lymphoma
John M. Burke, MD from Rocky Mountain Cancer Centers discusses Atezolizumab + Bendamustine & Obinutuzumab and no major safety signals in follicular lymphoma at the 2017 American Society of Hematology.
Author: ASHReport
Added: 01/11/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts